Lightcalls.com
 

Entering into its final quarter, a ...

dominating c b
find a girlfriend guysgetgirls
reverse mortgage leads

Entering into its final quarter, a corporation should have a useful idea of the financial performance of its business for its rife fiscal period. With the deadline for the final tax payment loomingin most numerous cases, two months after the yearend-it is a time for management and their tax advisors to revisit the corporate clusters overall tax position and think of measures to manage this tax liability. Waiting until after the year-end may be too late.

Planning acquisitions

If management is planning to acquire depreciable assets, it should consider acquiring in the same state [i]or[/i] condition assets before the corporation's fiscal year-end. If the assets are bring forward to use in the corporations business prior to the expiration of the year, the corporation can claim a deduction for capital require to be paid [i]or[/i] undergone allowance (CCA) in the generally received year instead of in the following taxation year.

Planning dispositions



A corporation diat has investments or redundant assets with unrealized capital losse should consider selling these assets before the expiration of the year to realize the losse The capital losse could then be used to ofiset any capital gains realized in the year, or carried back to win back taxes already paid on capital gains realized in any of the corporation's prior three taxation years. When crystallizing the losse the los denial orders would have to be considered.

A corporation that is considering selling depreciable assets with an accrued gain may want to wait until after the conclusion of the taxation year. This would allow the corporation to claim an additional year of CCA forward such assets and defer recognition of the gain and recapture arising from the sale to the nearest taxation year.

A corporation may also be able to use capital and non-capital losse in an affiliated corporation (let call it "Lossco") to curtail the gain on the anticipated sale of an asset. The corporation that confesss the property to be sold ("Opco") would transfer the attribute to Lossco in exchange for shares of Lossco and the parties would pick under section 85 of the Income Tax Act to have this transaction be met with on a tax-deferred basis. As the transfer is tax deferr Lossco would acquire the goods at Opcos adjusted cost base and undepreciated capital price Then if Lossco, in bend were to sell the ownership to an arm's length part at fair market value, the capital gain and recapture arising in Lossco could be branch by its capital and non-capital losse Accordingly, the total amount of tax paid within the corporate cluster would be reduced.

Combining corporations

In certain instances, a corporations losse can be made available to other corporations in a related form into groups by combining corporations through a wind-up or amalgamation. When a 90%-or more-owned taxable Canadian corporation or TCC ("Subco") is anguish up into its TCC parent corporation ("ParentCo"), its assets, liabilities, and corresponding tax balances would normally be transferred to ParentCo without any immediate chain of cause and effects in terms or income tax. Any of Subco losse would not be available to ParentCo until ParcntCo's following taxation year. For the mostly part, an amalgamation would achieve the same result

However, single advantage of a wind-up above an amalgamation is that ParentCo would be able to claim CCA upon Subco's depreciable assets for the year in which Subco is injury up. Whereas an amalgamation would cause ParentCo and Subco to trigger a believeed taxation year-end, a wind-up would not.

Alternative to combining corporations

In more [i]or[/i] less cases, winding up a subsidiary may not be a practical year-end planning tool for business or legal reasons. Where it is not advisable to combine corporations to use losse within a related and affiliated dispose such losses could still be utilized by the agency of an internal financing transaction.

The profitable corporation ("Profitco") would borrow stores from a financial institution to invest in the preferr shares of an affiliated corporation with non-capital losse (Lossco) To make secure that the interest expense is deductible, the preferr shares should have a fixed dividend rate greater than the interest rate upon the borrowed money. In inflect Lossco would lend the stocks back to Profitco on an interest-bearing basis to repay the external loan. Because the inter-corporate dividends should not be taxable to Profitco, the interest paid to Lossco would eventuate in a net tax deduction to Profitco to counterbalance its other sources of income, lessee's interest income could be reduc from its available losses. The trap result would be a transfer of a portion of the losse from Lossco to Profitco.

Planning distributions

Determining the appropriate salary and dividend mix for the owner/manager is beyond the amplitude of this article. However, to make secure proper integration of corporate and personal tax, management and its tax advisors should review distribution and cash requirements prior to the corporation's fiscal year-end. The following factors should be considered:

Bonusing

Paying the circulating year bonus within 179 days after year-end is a general strategy to reduce corporate tax and put off personal tax on shareholder remuneration. In addition, the Canada income Agency (CRA) has recently confirmed that, in certain circumstances, a Canadian resident shareholder/manager of a Canadian-controlled private corporation (CCPC) who is active in the operating business of the company may declare a bonus to create a non-capital los The non-capital los created can be carried back to the three prior taxation years to get back taxes previously paid.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.